News & Updates

Pseudopyloric metaplasia does not predict development of gastric cancer
Pseudopyloric metaplasia does not predict development of gastric cancer
10 Oct 2021

Neither gastric cancer nor gastric dysplasia is seen in patients with corpus atrophic gastritis (CAG) characterized at baseline with corpus pseudopyloric metaplasia (PPM) without corpus intestinal metaplasia (IM) because such lesions are consistently associated with corpus IM, reports a study.

Pseudopyloric metaplasia does not predict development of gastric cancer
10 Oct 2021
ACE inhibitors, ARBs put brakes on emphysema progression, lung function decline in COPD
ACE inhibitors, ARBs put brakes on emphysema progression, lung function decline in COPD
10 Oct 2021
Targeted therapy superior to chemotherapy, best supportive care at improving survival in NSCLC
Targeted therapy superior to chemotherapy, best supportive care at improving survival in NSCLC
09 Oct 2021

Survival benefit in patients with de novo stage IV nonsmall-cell lung cancer (NSCLC) depends on the type of treatment received, with significantly better median overall survival (OS) seen with the use of small-molecule targeted therapy against epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements than with best supportive care, reports a study.

Targeted therapy superior to chemotherapy, best supportive care at improving survival in NSCLC
09 Oct 2021
Acute pancreatitis on the rise worldwide
Acute pancreatitis on the rise worldwide
09 Oct 2021

Acute pancreatitis has seen a steady increase in worldwide incidence over the last five decades, particularly in Western countries, a recent study has found.

Acute pancreatitis on the rise worldwide
09 Oct 2021